Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Menicon Co's Revenue for the
three
months ended in Mar. 2026 was €172.7 Mil. Menicon Co's average Accounts Receivable for the
three
months ended in Mar. 2026 was €81.8 Mil.
Hence, Menicon Co's Receivables Turnover for the
three
months ended in Mar. 2026 was 2.11.
Menicon Co (FRA:5FR) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Menicon Co Receivables Turnover Related Terms
Menicon Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Menicon Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:5FR vs ISRG, BDX, MDLN: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, Menicon Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Menicon Co Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Menicon Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Menicon Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Menicon Co (FRA:5FR) has a Receivables Turnover of 2.11 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Menicon Co and its competitors. According to the industry distribution chart, Menicon Co ranks #134 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 16.5%.
Is Menicon Co's Receivables Turnover too high?
Menicon Co's current Receivables Turnover is 2.11. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Menicon Co's value of 2.11 is 61.7% below this industry median. Based on the distribution chart, Menicon Co ranks #134 out of 812 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Menicon Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Menicon Co's Receivables Turnover compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Menicon Co ranks #134 out of 812 companies for Receivables Turnover. This places Menicon Co in the top 17% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.51. Menicon Co's value of 2.11 is 61.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Menicon Co's current Receivables Turnover of 2.11 is 61.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Menicon Co and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Menicon Co's current Receivables Turnover is 2.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Menicon Co stock overvalued right now?
Menicon Co (FRA:5FR) has a current Receivables Turnover of 2.11. The stock's GF Value™ is €9.01, compared to a current price of €9.05 — trading 0.4% above its estimated fair value. The current Receivables Turnover is 2.11 and 61.7% below the Medical Devices & Instruments industry median of 5.51. Menicon Co's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Menicon Co (FRA:5FR), the current Receivables Turnover is 2.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Menicon Co (FRA:5FR) Overvalued in 2026?
Based on GuruFocus' analysis, Menicon Co stock appears to be overvalued.
The current stock price of €9.05 is trading 0.4% above its estimated GF Value™ of €9.01.
Key valuation signals for FRA:5FR:
Receivables Turnover: 2.11
GF Value™: €9.01 vs. price of €9.05 (0.4% above fair value)
Industry Position: 61.7% below the Medical Devices & Instruments median (#134 of 812)
No single metric tells the full story. See the FRA:5FR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Menicon Co Ltd is a contact lens manufacturing company. It is involved in manufacturing, sales, export, and import of contact lenses and other medical goods, manufacturing and sales of medical instruments, sales of medical supplies and research and development of intraocular lenses. The firm's products include soft lenses, gas permeable lenses and lens care products.
89GF Score
Get the complete analysis for FRA:5FR
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5FR has been successfully added to your 
